Rejection of kidney graft: Mechanism and prevention;Rejet de la greffe rénale : Mécanisme et prévention

Nephrologie et Therapeutique

Volumn 7, Issue 1, 2011, Pages 18-26

  Brick, Chehrazade ^a,c   Atouf, Ouafa ^a,b   Benseffaj, Nadia ^a,b   Essakalli, Malika ^a,b  

^a IBN SINA HOSPITAL   (Morocco)

^b MOHAMMED V UNIVERSITY   (Morocco)

^c Avenue Fal Ould Omeir ^*  (Morocco)

Author keywords

Allograft rejection; C4d; Immunological monitoring; Immunosuppressors; Renal biopsy; TLR

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; GRAFT FAILURE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MONITORING;

EID: 79751514439     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2010.10.002     Document Type: Short Survey

References (74)

1. D.J. Cohen, L.L. Christensen, R.D. Bloom, and R.S. Sung Kidney and pancreas transplantation in the United States, 1995-2004 Am J Transplant 6 2006 1153 1169
2. B. Samstein Choosing between immunity and tolerance after transplantation Cell Immunol 248 2007 44 47 (Pubitemid 350101458)
3. W.G. Land Innate alloimmunity: history and current knowledge Exp Clin Transplant 5 2007 575 584 (Pubitemid 47263365)
4. K. Mizutani, P. Terasaki, A. Rosen, V. Esquenazi, J. Miller, and R.N.J. Shih Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure Am J Transplant 5 2005 2265 2272 (Pubitemid 41648475)
5. K. Mizutani, P. Terasaki, R.N.J. Shih, R. Pei, M. Ozawa, and J. Lee Frequency of MIC antibody in rejected renal transplant patients without HLA antibody Hum Immunol 67 2006 223 229 (Pubitemid 43673928)
6. D. Dragun, D.N. Muller, J.H. Brasen, L. Fritsche, M. Nieminen-Kelha, and R. Dechend Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection N Engl J Med 352 2005 558 569 (Pubitemid 40204669)
7. S.A. Joosten, M.G. Van Dixhoorn, M.C. Borrias, H. Benediktsson, P.A. Van Veelen, and C. Van Kooten Antibody response against percalan and collagen types IV and VI in chronic renal allograft rejection in the rat Am J Pathol 160 2002 1301 1310 (Pubitemid 34411634)
8. H. Kanzler, F.J. Barrat, E.M. Hessel, and R.L. Coffman Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nat Med 13 2007 552 559 (Pubitemid 46830615)
9. K. Lolmde, and P. Rovere-Querini Rôle du facteur high mobility group box 1 (HMGB1) dans l'induction des réponses immunitaires dirigées contre les cellules mortes Pathol Biol 57 2009 217 218
10. M. Essakalli, O. Atouf, N. Bennani, N. Benseffaj, S. Ouadghiri, and C. Brick Toll-like récepteurs Pathol Biol 57 2009 430 438
11. E. Nogueira, V. Campos Ponciano, E.L. Naka, G.D.M. Marques, M.A. Cenedeze, and N.O. Saraiva Câmara Toll-like receptors-related genes in kidney transplant patients with chronic allograft nephropathy and acute rejection Int Immunopharmacol 9 2009 673 676
12. D.R. Goldstein Toll-like receptors and allograft rejection Transpl Immunol 17 2006 11 15
13. S. Jiang, O. Herrera, and R.I. Lechler New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance Curr Opin Immunol 16 2004 550 557 (Pubitemid 39165880)
14. M.R. Gökmen, G. Lombardi, and R.I. Lechler The importance of the indirect pathway of allorecognition in clinical transplantation Curr Opin Immunol 20 2008 568 574
15. O.B. Herrera, D. Golshayan, R. Tibbott, F. Salcido Ochoa, M.J. James, and F.M. Marelli-Berg A novel pathway of alloantigen presentation by dentritic cells J Immunol 173 2004 4828 4837 (Pubitemid 39387763)
16. C. Legendre, J. Zuber, D. Anglicheau, M. Le Quintrec, F. Martinez, and M.F. Mamzer-Bruneel Immunosuppression en transplantation rénale Ann Urol (Paris) 41 2007 276 284
17. E. Thervet, J. Zuber, R. Sberro, G. Canaud, D. Anglicheau, and R. Snanoudj Traitements immunosuppresseurs : mécanismes d'action et utilisation clinique EMC, Néphrologie 2009 [18-065-F-10]
18. C. Legendre Les nouvelles modalités de suivi des patients transplantés rénaux Nephrol Ther 4 2008 S1 S2
19. Y. Futagawa, and P.I. Terasaki ABO incompatible kidney transplantation-an analysis of UNOS Registry data Clin Transplant 20 2005 122 126 (Pubitemid 43349037)
20. C.C. Magee Transplantation across previously incompatible immunological barriers Transpl Int 19 2006 87 97
21. S.E. Aydingoz, S.K. Takemoto, B.W. Pinsky, P.R. Salvalaggio, K.L. Lentine, and L. Willoughby The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage Hum Immunol 68 2007 491 499 (Pubitemid 46726855)
22. J.P. Roberts, R.A. Wolfe, J.L. Bragg-Gresham, S.H. Rush, J.J. Wynn, and D.A. Distant Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups N Engl J Med 350 2004 545 551 (Pubitemid 38160784)
23. V. Moalic Comment est réalisé un typage HLA ? Reanimation 17 2008 407 411
24. P.I. Terasaki, and J.D. Mac Clelland Microdroplet assay of human serum cytotoxins Nature 204 1964 998 1000
25. V. Moalic, B. Mercier, and C. Ferec Technologie Luminex™ : principe, applications et perspectives Immunoanal Biol Spec 19 2004 181 187 (Pubitemid 39286186)
26. V. Moalic, and C. Ferec Typage HLA, méthodes d'analyses et applications cliniques Presse Med 34 2005 1101 1108 (Pubitemid 41330074)
27. A. Cesbron-Gautier, P. Simon, L. Achard, S. Cury, G. Follea, and J.D. Bignon Technologie Luminex : application aux typages HLA par biologie moléculaire (PCR-SSO) et l'identification des anticorps anti-HLA Ann Biol Clin (Paris) 62 2004 93 98 (Pubitemid 38215435)
28. S.A. Dunbar Applications of Luminex xMAP™ technology for rapid, high throughput multiplexed nucleic acid detection Clin Chim Acta 363 2006 71 82 (Pubitemid 41745226)
29. L.D. Osowski, J. Jakubek, M. Woronkowicz, N. Littleton, and D. Kukuruga The Luminex™ microbead array assay is an excellent sequence specific oligonucleotide probe (SSOP) method for HLA-A, B, DR antigen level typing Hum Immunol 64 Suppl. 10 2003 S97
30. J. Cai, and P.I. Terasaki Humoral theory of transplantation: mechanism, prevention and treatment Hum Immunol 66 2005 334 342 (Pubitemid 40615787)
31. M. Quanzong, P.I. Terasaki, J. Cai, N. El-Awar, and L. Rebellato Analysis of HLA class I specific antibodies in patients with failed allografts Transplantation 83 2007 54 61 (Pubitemid 46104971)
32. F.H. Claas, M.D. Witvliet, R.J. Duquesnoy, G.G. Persijn, and I.I. Doxiadis The acceptable mismatch program as a fast tool for highly sensitized patients awaiting cadaveric kidney transplantation: short waiting time and excellent graft outcome Transplantation 78 2004 190 193
33. C. Antoine Les stratégies de greffe chez les patients immunisés ou hyperimmunisés Nephrol Pathol 5 2008 S174 S178
34. R.J. Duquesnoy, M.D. Witvliet, I.I. Doxiadis, H. De Fijter, and F.H.J. Claas HLA Matchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates Transpl Int 17 2004 22 30 (Pubitemid 38197023)
35. C. Legendre, D. Anglicheau, A. Loupy, J. Zuber, L.H. Noël, and N. Patey Transplantation rénale chez les patients « haut risque immunologique » Actual Nephrol 21 2007 225 235
36. A. Piazza, E. Poggi, G. Ozzella, L. Borrelli, P.I. Monaco, and A. Scornajenghi Public epitope specificity of HLA class I antibodies induced by failed kidney transplant: alloantibody characterization by flow cytometric techniques Transplantation 81 2006 1298 1305 (Pubitemid 43804550)
37. N. El-Awar, J. Lee, and P.I. Terasaki HLA antibody identification with single antigen beads compared to conventional methods Hum Immunol 66 2005 989 997 (Pubitemid 41790535)
38. D. Phelan, T. Mohanakumar, S. Ramachandran, and M. Jendrisak Living donor renal transplantation in the presence of donor-specific human leukocyte antibody detected by solid-phase assay Hum Immunol 70 2009 584 588
39. M.R. Garovoy, M.A. Rheinschmilt, M. Bigos, H. Perkins, B. Colombe, and N. Feduska Flow cytometry analysis: a high technology cross-match technique facilitating transplantation Transplant Proc 15 1983 1939 1942
40. H.S. Eng, G. Bennett, P. Bardy, P. Coghlan, G. Russ, and P.T.H. Coates Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools Hum Immunol 70 2009 595 599
41. R.A. Montgomery, A.A. Zachary, L.C. Racusen, M.S. Leffell, K.E. King, and J. Burdick Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients Transplantation 70 2000 887 895
42. D. Glotz, C. Antoine, P. Julia, B. Pegaz-Fiornet, A. Duboust, and S. Boudjeltia Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies Transpl Int 17 2004 1 8 (Pubitemid 38197020)
43. C. Lefaucheur, D. Nochy, J. Andrade, J. Verine, C. Gautreau, and D. Charron Comparison of combination plasmapheresis/IV Ig/anti-CD20 versus high-dose IV Ig in the treatment of antibody-mediated rejection Am J Transplant 9 2009 1099 1107
44. J. Zuber Quoi de neuf dans le monitoring immunologique en transplantation cellulaire ? Nephrol Ther 4 2008 S3 S7
45. A. Hulin Mécanismes moléculaires de l'activité des immunosuppresseurs actuels en transplantation : rôles du pharmacien Ann Pharm Fr 66 2008 102 114
46. C. Mariat Les nouvelles molécules en transplantation Nephrol Ther 5 2009 S400 S404
47. A. Hertig, and E. Rondeau Immunomodulation dans la greffe rénale : ce qui a changé en 20 ans Reanimation 15 2006 253 258
48. P.I. Terasaki Humoral theory of transplantation Am J Transplant 3 2003 665 673 (Pubitemid 36745238)
49. P.I. Terasaki, and J. Cai Humoral theory of transplantation: further evidence Curr Opin Immunol 17 2005 541 545 (Pubitemid 41207959)
50. R. Pelletier, P. Hennessy, A. Van Buskirk, R. Erguson, and C. Orosz Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation Am J Transplant 2 2002 134 141 (Pubitemid 36306792)
51. Q. Mao, P. Terasaki, J. Cai, K. Briley, P. Catrou, and C. Haisch Extremely high association between appearance of HLA antibodies and failure of kidney grafts in five-year longitudinal study Am J Transplant 7 2007 864 871 (Pubitemid 46481194)
52. P.I. Terasaki, and M. Ozawa Predicting kidney graft failure by HLA antibodies: a prospective trial Am J Transplant 4 2004 438 443 (Pubitemid 38282302)
53. M. Ozawa, P. Terasaki, J. Lee, R. Castro, J. Alberu, and C. Alonso 14th International HLA and immunogenetics worshop: report on the prospective chronic rejection project Tissue Antigens 69 2007 174 179 (Pubitemid 46625879)
54. M. Büchler Rôle des anticorps anti-HLA dirigés contre le donneur ou non au cours de la dysfonction chronique du greffon rénal Nephrol Ther 5 2008 S200 S203
55. D. Glotz Intérêt du monitoring du rejet aigu médié par anticorps post-transplantation ? Nephrol Ther 4 2008 S8 S12
56. S. Rotman, B. Collins, and T. Colvin C4d deposition in allografts: current concepts and interpretation Transplant Rev 19 2005 65 77 (Pubitemid 41194913)
57. K.J. Tinckam, and A. Chandraker Mechanisms and role of HLA and non-HLA alloantibodies Clin J Am Soc Nephrol 1 2006 404 414
58. C. Jianghua, X. Wenqing, W. Huiping, J. Juan, W. Jianyong, and H. Qiang C4d as a significant predictor for humoral rejection in renal allografts Clin Transplant 19 2005 785 791 (Pubitemid 41748733)
59. A.B. Collins, E. Schneeberger, M. Pascual, S. Saidman, W. Williams, and N. Tolkoff-Rubin Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries J Am Soc Nephrol 10 1999 2208 2214 (Pubitemid 29453499)
60. H. Regele, G.A. Böhmig, A. Habicht, D. Gollowitzer, M. Schillinger, and S. Rockenschaub Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection J Am Soc Nephrol 13 2002 2371 2380 (Pubitemid 34925248)
61. H.E. Feucht, E. Felber, M.J. Gokel, G. Hillebrand, U. Nattermann, and C. Brockmeyer Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection Clin Exp Immunol 86 1991 464 470
62. H.E. Feucht, H. Schneeberger, G. Hillebrand, K. Burkhardt, M. Weiss, and W. Land Capillary deposition of C4d complement fragment and early graft loss Kidney Int 43 1993 1333 1338 (Pubitemid 23161421)
63. G.A. Bohmig, M. Exner, A. Habicht, M. Schillinger, U. Lang, and J. Kletzmayr Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury J Am Soc Nephrol 13 2002 1009 1091
64. S. Onitsuka, Y. Yamaguchi, K. Tanabe, K. Takahashi, and H. Toma Peritubular capillary deposition of C4d complement fragment in ABO-incompatible renal transplantation with humoral rejection Clin Transplant 13 1999 33 37 (Pubitemid 30136013)
65. L. Ghisdal, G. Touchard, J.M. Goujon, D. Buob, D. Durand, and G. Mourad Premier épisode de rejet aigu aprs transplantation rénale : étude des caractéristiques histopathologiques en fonction du risque immunologique du patient Nephrol Ther 4 2008 173 180 (Pubitemid 351763925)
66. V. Nickeleit, M. Zeiler, F. Gudat, G. Thiel, and M.J. Mihatsch Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications J Am Soc Nephrol 13 2002 242 251 (Pubitemid 34042034)
67. B. Watschinger, and M. Pascual Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection J Am Soc Nephrol 13 2002 2420 2423 (Pubitemid 34925254)
68. L.H. Noël, and C. Legendre Intérêt des biopsies systématiques du greffon rénal ? Nephrol Ther 4 2008 S18 S24
69. L.C. Racusen Classification de Banff : rejets cellulaire et humoral Actualités néphrologiques 2005 Flammarion Médecine-Sciences 231 237
70. K. Solez, R.B. Colvin, L.C. Racusen, B. Sis, P.F. Halloran, and P.E. Birk Banff'05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') Am J Transplant 7 2007 518 526 (Pubitemid 46376465)
71. L.C. Racusen, and M. Haas Antibody-mediated rejection in renal allografts: lessons from pathology Clin J Am Soc Nephrol 1 2006 415 420
72. C. Lefaucheur, D. Nochy, and D. Glotz Rejet aigu médié par anticorps Nephrol Ther 5 2008 S188 S191
73. A. Salama, and C.D. Pusey Drug insight: rituximab in renal disease and transplantation Nat Clin Pract Nephrol 2 2006 221 230 (Pubitemid 43787288)
74. L. Adorini, and G. Penna Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists Hum Immunol 70 2009 345 352